- 全部删除
您的购物车当前为空
AU-15330是一种蛋白水解靶向嵌合体 (PROTAC),AU-15330同时靶向 SMARCA4、SMARCA2 和 PBRM1 进行降解,在 H3.3K27M细胞中表现出细胞毒性,但在 H3 野生型细胞中则不具有细胞毒性。[2]


为众多的药物研发团队赋能,
让新药发现更简单!
AU-15330是一种蛋白水解靶向嵌合体 (PROTAC),AU-15330同时靶向 SMARCA4、SMARCA2 和 PBRM1 进行降解,在 H3.3K27M细胞中表现出细胞毒性,但在 H3 野生型细胞中则不具有细胞毒性。[2]
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,280 | In stock | |
| 5 mg | ¥ 3,270 | In stock | |
| 10 mg | ¥ 4,890 | In stock | |
| 25 mg | ¥ 7,470 | In stock | |
| 50 mg | ¥ 9,870 | In stock | |
| 100 mg | ¥ 13,500 | In stock | |
| 200 mg | ¥ 18,300 | In stock |
AU-15330 相关产品
| 产品描述 | AU-15330 is a proteolytic targeting chimera (PROTAC) that simultaneously targets SMARCA4, SMARCA2, and PBRM1 for degradation and exhibits cytotoxicity in H3.3K27M cells but not in H3 wild-type cells. [2] |
| 体外活性 | 方法:用不同浓度的 AU-15330(0.1,1μM) 处理PCa 细胞(LNCaP、VCaP、22RV1 和 LAPC4), |
| 体内活性 | 方法:VCaP和C4-2B 去势抵抗性肿瘤模型小鼠用AU-15330(60mg kg,i.v),每周 3 天。 |
| 分子量 | 755.93 |
| 分子式 | C39H49N9O5S |
| CAS No. | 2380274-50-8 |
| Smiles | C[C@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H](NC(=O)CN1CCN(CC1)c1cc(nnc1N)-c1ccccc1O)C(C)(C)C)c1ccc(cc1)-c1scnc1C |
| 存储 | keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 252.5 mg/mL (334.03 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容